The make DEEP Human Families Blog

Posts

August 18, 2026

New diabetes clinical trial: Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Published on: 2026-08-18T04:00:00Z Conditions : Overweight; Obesity Interventions : Drug: Semaglutide; Drug: Placebo Sponsors : Novo Nordisk A/S Recruiting https://ift.tt/HibZLnp

Search This Blog

The make DEEP Human Families Blog

Posts

Helping the Crippled 2 God

The Temple of TRANCE Health Portal

TRANCEatable by Pharmakon Health Cloud

TRANCEForm my Plate Seminars and DEEP Summit

Emergent APHID Helpful Resources

Make DEEP Humans a Divided Line

Computational Arrays and Objects for Scientific and Med Lab Research Featured Post

New diabetes clinical trial: Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Latest Posts

New diabetes clinical trial: Evaluating Food Messaging Campaigns for Young Adults

New diabetes clinical trial: Effects of BFRT on Glycemic Control, Nerve Conduction, Functional Outcomes and QOL in Individuals With Type 2 Diabetes

New diabetes clinical trial: Clinical and Radiographic Evaluation of Subgingival 1% Metformin Gel Versus 0.05% Zoledronate Gel as an Adjunct to MINST of Intrabony Defects in Controlled Type 2 DM

New diabetes clinical trial: Lactoferrin Supplementation in Diabetic Nephropathy

New diabetes clinical trial: Development and Validation of a Scale of Propensity for Change in Chronic Disease Prevention

New diabetes clinical trial: Polygonatum Sibiricum Reduces Visceral Fat in Obese Adults

New diabetes clinical trial: Study of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults With Type 1 Diabetes

New diabetes clinical trial: Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With Diabetic Retinopathy in a Random Sample of Retinal Fundus Photographs

New diabetes clinical trial: Effects of Intermittent Fasting Variations on Nutrigenomic Profile, Metabolic Parameters, Inflammation, and Body Composition in Prediabetic Patients

New diabetes clinical trial: Evaluation of Subgingival 1% Metformin Gel Versus 0.05% Zoledronate Gel as an Adjunct to MINST of Intrabony Defects in Controlled Type 2 DM